Literature DB >> 28494505

Genome-wide analysis of somatic copy number alterations and chromosomal breakages in osteosarcoma.

Jan Smida1,2,3, Hongen Xu4, Yanping Zhang4, Daniel Baumhoer5, Sebastian Ribi5, Michal Kovac5, Irene von Luettichau3, Stefan Bielack6, Valerie B O'Leary1, Christine Leib-Mösch7, Dmitrij Frishman4,8,9, Michaela Nathrath2,3,10.   

Abstract

Osteosarcoma (OS) is the most common primary malignant bone tumor in children and adolescents. It is characterized by highly complex karyotypes with structural and numerical chromosomal alterations. The observed OS-specific characteristics in localization and frequencies of chromosomal breakages strongly implicate a specific set of responsible driver genes or a specific mechanism of fragility induction. In this study, a comprehensive assessment of somatic copy number alterations (SCNAs) was performed in 160 OS samples using whole-genome CytoScan High Density arrays (Affymetrix, Santa Clara, CA). Genes or regions frequently targeted by SCNAs were identified. Breakage analysis revealed OS specific unstable regions in which well-known OS tumor suppressor genes, including TP53, RB1, WWOX, DLG2 and LSAMP are located. Certain genomic features, such as transposable elements and non-B DNA-forming motifs were found to be significantly enriched in the vicinity of chromosomal breakage sites. A complex breakage pattern-chromothripsis-has been suggested as a widespread phenomenon in OS. It was further demonstrated that hyperploidy and in particular chromothripsis were strongly correlated with OS patient clinical outcome. The revealed OS-specific fragility pattern provides novel clues for understanding the biology of OS.
© 2017 UICC.

Entities:  

Keywords:  SCNAs; chromosomal breakage pattern; chromothripsis; driver genes; osteosarcoma

Mesh:

Year:  2017        PMID: 28494505     DOI: 10.1002/ijc.30778

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  28 in total

1.  Targeted transcriptional profiling of the tumor microenvironment reveals lymphocyte exclusion and vascular dysfunction in metastatic osteosarcoma.

Authors:  Laurie Sorenson; Yanfen Fu; Tressa Hood; Sarah Warren; Troy A McEachron
Journal:  Oncoimmunology       Date:  2019-06-27       Impact factor: 8.110

2.  Cancer mutational burden is shaped by G4 DNA, replication stress and mitochondrial dysfunction.

Authors:  Albino Bacolla; Zu Ye; Zamal Ahmed; John A Tainer
Journal:  Prog Biophys Mol Biol       Date:  2019-03-14       Impact factor: 3.667

3.  TET2-dependent IL-6 induction mediated by the tumor microenvironment promotes tumor metastasis in osteosarcoma.

Authors:  Hitoshi Itoh; Tsuyoshi Kadomatsu; Hironori Tanoue; Masaki Yugami; Keishi Miyata; Motoyoshi Endo; Jun Morinaga; Eisuke Kobayashi; Takeshi Miyamoto; Ryoma Kurahashi; Kazutoyo Terada; Hiroshi Mizuta; Yuichi Oike
Journal:  Oncogene       Date:  2018-03-08       Impact factor: 9.867

4.  Profiling targetable immune checkpoints in osteosarcoma.

Authors:  Troy A McEachron; Timothy J Triche; Laurie Sorenson; David M Parham; John D Carpten
Journal:  Oncoimmunology       Date:  2018-09-11       Impact factor: 8.110

5.  CDH4 is a novel determinant of osteosarcoma tumorigenesis and metastasis.

Authors:  Qinglian Tang; Jinchang Lu; Changye Zou; Yang Shao; Yan Chen; Swami Narala; Hui Fang; Huaiyuan Xu; Jin Wang; Jingnan Shen; Rama Khokha
Journal:  Oncogene       Date:  2018-04-03       Impact factor: 9.867

6.  Chromosome painting and its applications in cultivated and wild rice.

Authors:  Lili Hou; Meng Xu; Tao Zhang; Zhihao Xu; Weiyun Wang; Jianxiang Zhang; Meimei Yu; Wen Ji; Cenwen Zhu; Zhiyun Gong; Minghong Gu; Jiming Jiang; Hengxiu Yu
Journal:  BMC Plant Biol       Date:  2018-06-07       Impact factor: 4.215

Review 7.  Unlocking the NF-κB Conundrum: Embracing Complexity to Achieve Specificity.

Authors:  Federica Begalli; Jason Bennett; Daria Capece; Daniela Verzella; Daniel D'Andrea; Laura Tornatore; Guido Franzoso
Journal:  Biomedicines       Date:  2017-08-22

Review 8.  Regulatory Role of N6-methyladenosine (m6A) Modification in Osteosarcoma.

Authors:  Yujie Zhang; Yanyan Wang; Liwei Ying; Sifeng Tao; Mingmin Shi; Peng Lin; Yangxin Wang; Bin Han
Journal:  Front Oncol       Date:  2021-05-19       Impact factor: 6.244

9.  Charting a path for prioritization of novel agents for clinical trials in osteosarcoma: A report from the Children's Oncology Group New Agents for Osteosarcoma Task Force.

Authors:  Sarah B Whittle; Katharine Offer; Ryan D Roberts; Amy LeBlanc; Cheryl London; Robbie G Majzner; Alex Y Huang; Peter Houghton; E Alejandro Sweet Cordero; Patrick J Grohar; Michael Isakoff; Michael W Bishop; Elizabeth Stewart; Emily K Slotkin; Emily Greengard; Scott C Borinstein; Fariba Navid; Richard Gorlick; Katherine A Janeway; Damon R Reed; Pooja Hingorani
Journal:  Pediatr Blood Cancer       Date:  2021-06-16       Impact factor: 3.838

10.  Chromothripsis 18 in multiple myeloma patient with rapid extramedullary relapse.

Authors:  Jan Smetana; Jan Oppelt; Martin Štork; Luděk Pour; Petr Kuglík
Journal:  Mol Cytogenet       Date:  2018-01-18       Impact factor: 2.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.